Company / Operating Income
Traws Pharma, Inc. Operating Income History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$142.4M
FY2024
5-year range
-$142.4M / -$16.5M
FY2020-FY2024
Trend
-625.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income changed -625% YoY in FY2024, a notable deviation from the 9-year average annual change of -62%.
Based on SEC 10-K filings.
-$142M in FY2024.
Declined from -$16M to -$142M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating income decreased 625.4% year-over-year.
- Peak operating income was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$142.4M | -625.4% |
| FY2023 | -$19.6M | -19.0% |
| FY2022 | -$16.5M | +34.0% |
| FY2021 | -$25.0M | -15.2% |
| FY2020 | -$21.7M | +6.8% |
| FY2019 | -$23.3M | +9.5% |
| FY2018 | -$25.7M | -8.6% |
| FY2017 | -$23.7M | +1.1% |
| FY2016 | -$24.0M | +62.4% |
| FY2015 | -$63.7M | -186.1% |
As of FY2024 · SEC 10-K Annual Filings · Last checked Jun 28, 2026